Literature DB >> 33463859

Typologies of illicit drug use in mid-adulthood: a quasi-longitudinal latent class analysis in a community-based sample of twins.

Genevieve F Dash1, Nicholas G Martin2, Arpana Agrawal3, Michael T Lynskey4, Wendy S Slutske1.   

Abstract

AIMS: To identify drug use typologies based on substances used and persistence of use over two time points, use a genetically informed design to explore twin concordance of and genetic influence on the use typologies and compare patterns of declined/discontinued ("desistant") and persistent drug use on drug use correlates.
DESIGN: Latent class analysis was applied to data from a cross-sectional self-report survey on current and past drug use. Use characteristics, use disorder, and psychiatric problems were compared across classes.
SETTING: Computer-assisted telephone interview in respondents' homes. PARTICIPANTS: A total of 3785 individual twins and siblings (1365 men, 2420 women; Mage  = 32) from the Australian Twin Registry Cohort III. MEASUREMENTS: A comprehensive interview assessed prior to past year and past year use of cannabis, stimulants, cocaine/crack, hallucinogens, opioids, sedatives, inhalants, dissociatives, and solvents; age of first use; opportunity to use; peer drug use; attention deficit/hyperactivity, conduct, antisocial personality, depressive, and substance use disorders; and suicidality.
FINDINGS: A five-class solution emerged: no/low use (50%), desistant cannabis use (23%), desistant party drug use (18%), persistent prescription drug misuse (4%), and persistent polydrug use (5%). Twin concordances were higher among monozygotic (k = 0.30-0.35) than dizygotic pairs (same-sex k = 0.19-0.20; opposite sex k = 0.07), and biometric modeling suggested that the persistent polydrug use class, in particular, was highly heritable (a2  = 0.94). Conduct disorder (OR = 2.40), antisocial personality disorder (OR = 3.27), and suicidal ideation (OR = 1.98) increased persistent polydrug use risk; depression (OR = 2.38) and lifetime suicide attempt (OR = 2.31) increased persistent prescription misuse risk. Relative to persistent prescription drug misuse, persistent polydrug use was associated with higher rates of cannabis and stimulant use disorder (OR = 6.14-28.01), younger first substance use (OR = 0.82-0.83), more drug use opportunity (OR = 10.66-66.06), and more drug-using peers (OR = 4.66-9.20).
CONCLUSIONS: Unique patterns of declined/discontinued ("desistant") and persistent drug use are differentially heritable and differentially associated with risk factors, psychiatric symptoms, and substance use disorder outcomes. © 2020 Society for the Study of Addiction.

Entities:  

Keywords:  Illicit drugs; latent class analysis; persistent drug use; polydrug use; quasi-longitudinal; twin study

Mesh:

Substances:

Year:  2020        PMID: 33463859      PMCID: PMC7882637          DOI: 10.1111/add.15225

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  43 in total

1.  Ecstasy use in Australia: patterns of use and associated harm.

Authors:  L Topp; J Hando; P Dillon; A Roche; N Solowij
Journal:  Drug Alcohol Depend       Date:  1999-06-01       Impact factor: 4.492

2.  A comparison of patterns of methamphetamine and cocaine use.

Authors:  Sara L Simon; Kimberly Richardson; Jennifer Dacey; Susan Glynn; Catherine P Domier; Richard A Rawson; Walter Ling
Journal:  J Addict Dis       Date:  2002

3.  Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse.

Authors:  Alicia Grattan; Mark D Sullivan; Kathleen W Saunders; Cynthia I Campbell; Michael R Von Korff
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

4.  Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Wilson M Compton; Kevin P Conway; Frederick S Stinson; James D Colliver; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2005-06       Impact factor: 4.384

5.  Substance Use Trajectories From Early Adolescence Through the Transition to College.

Authors:  Karen J Derefinko; Richard J Charnigo; Jessica R Peters; Zachary W Adams; Richard Milich; Donald R Lynam
Journal:  J Stud Alcohol Drugs       Date:  2016-11       Impact factor: 2.582

6.  Gender effects on drug use, abuse, and dependence: a special analysis of results from the National Survey on Drug Use and Health.

Authors:  Jessica H Cotto; Elisabeth Davis; Gayathri J Dowling; Jennifer C Elcano; Anna B Staton; Susan R B Weiss
Journal:  Gend Med       Date:  2010-10

7.  Identifying subtypes of cannabis users based on simultaneous polysubstance use.

Authors:  Christal N Davis; Wendy S Slutske; Nicholas G Martin; Arpana Agrawal; Michael T Lynskey
Journal:  Drug Alcohol Depend       Date:  2019-10-28       Impact factor: 4.492

8.  Typology of club drug use among young adults recruited using time-space sampling.

Authors:  Danielle E Ramo; Christian Grov; Kevin Delucchi; Brian C Kelly; Jeffrey T Parsons
Journal:  Drug Alcohol Depend       Date:  2009-11-24       Impact factor: 4.492

9.  Gender differences in risk factors for aberrant prescription opioid use.

Authors:  Robert N Jamison; Stephen F Butler; Simon H Budman; Robert R Edwards; Ajay D Wasan
Journal:  J Pain       Date:  2009-11-27       Impact factor: 5.820

10.  A typology of prescription drug misuse: a latent class approach to differences and harms.

Authors:  Brian C Kelly; H Jonathon Rendina; Mike Vuolo; Brooke E Wells; Jeffrey T Parsons
Journal:  Drug Alcohol Rev       Date:  2014-09-06
View more
  1 in total

1.  Big Five personality traits and illicit drug use: Specificity in trait-drug associations.

Authors:  Genevieve F Dash; Nicholas G Martin; Wendy S Slutske
Journal:  Psychol Addict Behav       Date:  2021-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.